Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Xifeng WuM R Spitz

Abstract

Second primary tumors (SPTs) are a hallmark of head and neck squamous cell carcinomas (HNSCCs). Serum levels of insulin growth factors (IGFs) and their binding proteins (IGFBPs) have been associated with subsequent development of several epithelial cancers in prospective studies. To examine the role of IGFs in SPT development, we conducted a nested case-control study within a randomized, placebo-controlled chemoprevention trial in patients with early-stage HNSCC. We compared prediagnostic serum IGF-I and IGFBP-3 levels in 80 patients who subsequently developed SPTs and 173 controls (patients without SPTs) matched to the cases on age (+/-5 years), sex, ethnicity, year of randomization, and length of follow-up. The cases exhibited significantly higher levels of IGF-I and IGFBP-3 than did the controls (P = 0.001 and 0.019, respectively). Elevated IGF-I levels were associated with a 3.66-fold significantly increased risk of SPT. Lower and higher IGFBP-3 levels were associated with a 2.22- and 7.12-fold significant increased risk, respectively. The median SPT-free time was significantly shorter in patients with higher IGF-I levels than in patients with lower IGF-I levels (P < 0.0001). A similar trend was observed for IGFBP-3 (P = 0....Continue Reading

References

Oct 1, 1976·American Journal of Surgery·R H Jesse, E V Sugarbaker
Aug 31, 1990·Science·S M Cohen, L B Ellwein
Sep 1, 1989·International Journal of Radiation Oncology, Biology, Physics·J S CooperJ D Cox
Sep 1, 1989·International Journal of Radiation Oncology, Biology, Physics·S McDonaldL D Divers
Sep 1, 1989·International Journal of Radiation Oncology, Biology, Physics·J T LicciardelloW K Hong
Nov 1, 1984·The Annals of Otology, Rhinology, and Laryngology·J G Batsakis
May 15, 1994·International Journal of Cancer. Journal International Du Cancer·F el AtiqG Pommier
Jun 1, 1996·The International Journal of Biochemistry & Cell Biology·K M KelleyR G Rosenfeld
Mar 1, 1997·Cytokine & Growth Factor Reviews·D R Clemmons
Mar 13, 1998·Breast Cancer Research and Treatment·M E Del GiudiceP J Goodwin
Jan 29, 1999·Journal of the National Cancer Institute·H YuX Wu
Jul 30, 1999·Journal of Mammary Gland Biology and Neoplasia·E C Rosfjord, R B Dickson
May 4, 2000·Journal of the National Cancer Institute·X WuM R Spitz
Jun 27, 2000·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·W WangE Svanberg
Nov 10, 2000·International Journal of Cancer. Journal International Du Cancer·P TonioloA Zeleniuch-Jacquotte
Feb 17, 2001·American Journal of Physiology. Heart and Circulatory Physiology·T YamamuraH Imamura
May 29, 2001·Molecular Pathology : MP·J G ScharfG Ramadori
Jul 4, 2001·Drugs·R TorrisiG De Palo
Oct 13, 2001·Trends in Molecular Medicine·S A Bustin, P J Jenkins
Jan 15, 2002·Advances in Experimental Medicine and Biology·D L Hadsell, G Abdel-Fattah
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Anette WeberAndrea Tannapfel
May 16, 2002·Journal of the National Cancer Institute·Stephanie J LondonMimi C Yu
Jun 18, 2002·The Lancet Oncology·Gregor Fürstenberger, Hans-Jörg Senn
Jul 4, 2002·Journal of the National Cancer Institute·Manjinder S SandhuEdward L Giovannucci
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Apr 6, 2006·Journal of the National Cancer Institute·Sarah J FreemantleEthan Dmitrovsky
Mar 18, 2010·Current Opinion in Otolaryngology & Head and Neck Surgery·Patrick J Bradley, Paula T Bradley
Jul 23, 2014·PloS One·Mieke Van HemelrijckSabine Rohrmann
Jun 6, 2007·Future Oncology·Elizabeth G Nelson, Jennifer R Grandis
Jul 3, 2013·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kirsten H LimesandAndrew Fribley
Sep 17, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ranee MehraErica A Golemis
Nov 26, 2008·Oral Oncology·Jochen H LorchRobert I Haddad
Nov 23, 2006·International Journal of Oral and Maxillofacial Surgery·G BradyS J Crean
Nov 25, 2011·International Journal of Cancer. Journal International Du Cancer·Seung Hyun OhHo-Young Lee
Jun 15, 2010·Archives of Biochemistry and Biophysics·Monalisa SwainHanudatta S Atreya
Feb 28, 2006·Biochemical and Biophysical Research Communications·Mark G SlomianySteven A Rosenzweig
Jul 29, 2005·International Journal of Cancer. Journal International Du Cancer·Rajesh P DikshitR Sankaranarayanan
Sep 9, 2015·Advances in Preventive Medicine·Sandeep KumarLaxmi V Sukhtankar
Dec 3, 2014·Brazilian Journal of Otorhinolaryngology·Azadeh Andisheh-TadbirFereshteh Kamali
Oct 14, 2016·Cancer Medicine·Thurkaa ShanmugalingamMieke Van Hemelrijck
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sang Min ParkBong Yul Huh
Aug 1, 2012·Oncology Letters·Ying-Jian LiuBingyin Shi
May 31, 2015·The Oncologist·Tolutope OyasijiSteven N Hochwald
Dec 31, 2018·Aging·Valentina FrezzaFrancesca Bernassola
Jan 1, 2018·Archives of Gynecology and Obstetrics·Emre Özgür BuldukBurcu Biral Coşkun
Mar 22, 2014·Molecular and Clinical Oncology·Tirupati S Korampalli, Nicholas D Stafford
Mar 22, 2019·Current Nutrition Reports·Christian A Maino VieytesAnna E Arthur
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seung-Hyun OhHo-Young Lee
Dec 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xifeng WuMargaret R Spitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.